Testing ATAD2 as a new therapeutic target for advanced prostate cancer
Research Grant
Administered By
Pathology
Awarded By
University of California - Los Angeles
Start Date
July 1, 2024
End Date
June 30, 2029
Administered By
Pathology
Awarded By
University of California - Los Angeles
Start Date
July 1, 2024
End Date
June 30, 2029